Quick Answer
CITIUS ONCOLOGY, INC. reported Stockholders Equity of $44.87 million for fiscal year 2025.
CITIUS ONCOLOGY, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $44.87M | -2.8% |
| 2024 | $46.14M | +2421.5% |
| 2023 | -$1.99M | -107.8% |
| 2023 | $25.54M | +7290.8% |
| 2022 | $345.5K | -99.0% |
| 2022 | $36.27M | +358721.6% |
| 2021 | -$10.1K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $58.41M | +41.5% | +30.2% |
| September 30, 2025 | $44.87M | -2.8% | +38.5% |
| June 30, 2025 | $32.40M | +90.2% | -9.1% |
| March 31, 2025 | $35.64M | +79.6% | -13.7% |
| December 31, 2024 | $41.29M | +81.7% | -10.5% |
| September 30, 2024 | $46.14M | +80.7% | +170.9% |
| June 30, 2024 | $17.03M | +865489.3% | -14.2% |
| March 31, 2024 | $19.85M | +9944.6% | -12.7% |
- CITIUS ONCOLOGY, INC. showed a decrease of -2.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2025 period, CITIUS ONCOLOGY, INC.’s stockholders equity has grown by 443749.1% (from -$10.1 thousand to $44.87 million).
- The most recent figure is from CITIUS ONCOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: